These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


319 related items for PubMed ID: 32868906

  • 1. 10,11-dehydrocurvularin exerts antitumor effect against human breast cancer by suppressing STAT3 activation.
    Zhao Q, Bi Y, Zhong J, Li X, Guo J, Liu YX, Pan LR, Tan Y, Deng ZS, Yu XJ.
    Acta Pharmacol Sin; 2021 May; 42(5):791-800. PubMed ID: 32868906
    [Abstract] [Full Text] [Related]

  • 2. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
    Pan L, Chen X, Fu S, Yu W, Li C, Wang T, Lo HW, Lin J.
    Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
    [Abstract] [Full Text] [Related]

  • 3. Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.
    Gupta P, Srivastava SK.
    BMC Med; 2012 Jul 24; 10():80. PubMed ID: 22824293
    [Abstract] [Full Text] [Related]

  • 4. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J, Li RJ, Cheng MS, Kim YS.
    Cancer Lett; 2015 Feb 01; 357(1):393-403. PubMed ID: 25434800
    [Abstract] [Full Text] [Related]

  • 5. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer.
    Bharadwaj U, Eckols TK, Kolosov M, Kasembeli MM, Adam A, Torres D, Zhang X, Dobrolecki LE, Wei W, Lewis MT, Dave B, Chang JC, Landis MD, Creighton CJ, Mancini MA, Tweardy DJ.
    Oncogene; 2015 Mar 12; 34(11):1341-53. PubMed ID: 24681959
    [Abstract] [Full Text] [Related]

  • 6. Small molecule STAT3 inhibitor, 6Br-6a suppresses breast cancer growth in vitro and in vivo.
    Liu Z, Ge X, Gu Y, Huang Y, Liu H, Yu M, Liu Y.
    Biomed Pharmacother; 2020 Jan 12; 121():109502. PubMed ID: 31707351
    [Abstract] [Full Text] [Related]

  • 7. Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity.
    Jeon YJ, Jung SN, Yun J, Lee CW, Choi J, Lee YJ, Han DC, Kwon BM.
    Cancer Sci; 2015 Apr 12; 106(4):413-20. PubMed ID: 25611086
    [Abstract] [Full Text] [Related]

  • 8. A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.
    Zhang W, Yu W, Cai G, Zhu J, Zhang C, Li S, Guo J, Yin G, Chen C, Kong L.
    Cell Death Dis; 2018 Oct 27; 9(11):1098. PubMed ID: 30368518
    [Abstract] [Full Text] [Related]

  • 9. Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
    Liu CY, Tseng LM, Su JC, Chang KC, Chu PY, Tai WT, Shiau CW, Chen KF.
    Breast Cancer Res; 2013 Oct 27; 15(4):R63. PubMed ID: 23938089
    [Abstract] [Full Text] [Related]

  • 10. Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells.
    Lee J, Hahm ER, Singh SV.
    Carcinogenesis; 2010 Nov 27; 31(11):1991-8. PubMed ID: 20724373
    [Abstract] [Full Text] [Related]

  • 11. Methylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathways.
    Lim EJ, Hong DY, Park JH, Joung YH, Darvin P, Kim SY, Na YM, Hwang TS, Ye SK, Moon ES, Cho BW, Do Park K, Lee HK, Park T, Yang YM.
    PLoS One; 2012 Nov 27; 7(4):e33361. PubMed ID: 22485142
    [Abstract] [Full Text] [Related]

  • 12. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F, Dai C, Fu Y, Loo JF, Xia D, Gao SP, Ma Z, Chen Z.
    Oncotarget; 2016 Feb 23; 7(8):9462-76. PubMed ID: 26843613
    [Abstract] [Full Text] [Related]

  • 13. Acacetin Inhibits the Growth of STAT3-Activated DU145 Prostate Cancer Cells by Directly Binding to Signal Transducer and Activator of Transcription 3 (STAT3).
    Yun S, Lee YJ, Choi J, Kim ND, Han DC, Kwon BM.
    Molecules; 2021 Oct 14; 26(20):. PubMed ID: 34684783
    [Abstract] [Full Text] [Related]

  • 14. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.
    Neoplasia; 2010 Jan 14; 12(1):39-50. PubMed ID: 20072652
    [Abstract] [Full Text] [Related]

  • 15. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
    Behera R, Kumar V, Lohite K, Karnik S, Kundu GC.
    Carcinogenesis; 2010 Feb 14; 31(2):192-200. PubMed ID: 19926637
    [Abstract] [Full Text] [Related]

  • 16. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H, Tan YP, Zhao L, Wang L, Fu NJ, Zheng SP, Shen XF.
    Cell Death Dis; 2020 Jan 24; 11(1):63. PubMed ID: 31980595
    [Abstract] [Full Text] [Related]

  • 17. Oral administration of penta-O-galloyl-β-D-glucose suppresses triple-negative breast cancer xenograft growth and metastasis in strong association with JAK1-STAT3 inhibition.
    Lee HJ, Seo NJ, Jeong SJ, Park Y, Jung DB, Koh W, Lee HJ, Lee EO, Ahn KS, Ahn KS, Lü J, Kim SH.
    Carcinogenesis; 2011 Jun 24; 32(6):804-11. PubMed ID: 21289371
    [Abstract] [Full Text] [Related]

  • 18. A natural compound derivative P-13 inhibits STAT3 signaling by covalently inhibiting Janus kinase 2.
    Huang H, Niu J, Wang F, Hu L, Yu Q.
    Invest New Drugs; 2019 Jun 24; 37(3):452-460. PubMed ID: 30073465
    [Abstract] [Full Text] [Related]

  • 19. Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
    Chen J, Li N, Liu B, Ling J, Yang W, Pang X, Li T.
    Life Sci; 2020 May 01; 248():117469. PubMed ID: 32109485
    [Abstract] [Full Text] [Related]

  • 20. 2'-Hydroxycinnamaldehyde inhibits proliferation and induces apoptosis via signal transducer and activator of transcription 3 inactivation and reactive oxygen species generation.
    Yoon YJ, Kim YH, Lee YJ, Choi J, Kim CH, Han DC, Kwon BM.
    Cancer Sci; 2019 Jan 01; 110(1):366-378. PubMed ID: 30375708
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.